The evolution of proviral gp120 during the first year after seroconversion in HIV-1 subtype C infection was addressed in a case series of eight subjects. Multiple viral variants were found in two out of eight cases. Slow rate of viral RNA decline and high early viral RNA set point were associated with a higher level of proviral diversity from 0 to 200 days after seroconversion. Proviral divergence from MRCA over the same period also differed between subjects with slow and fast decline of viral RNA, suggesting that evolution of proviral gp120 early in infection may be linked to the level of viral RNA replication. Changes in the length of variable loops were minimal, and length reduction was more common than length increase. Potential N-linked glycosylation sites ranged ±one site, showing common fluctuations in the V4 and V5 loops. These results highlight the role of proviral gp120 diversity and diversification in the pathogenesis of acute HIV-1 subtype C infection.
Introduction
After decades of endemic evolution, HIV-1 has achieved enormous diversity in the worldwide HIV/AIDS epidemic, posing a significant challenge for an HIV vaccine design. A complex interplay between virus and host during HIV-1 infection results in the gradual accumulation of provirus variants. The constantly growing repertoire of archived proviral sequences represents a history of virus replication within the host, providing a continuous source for subsequent HIV replication and transmission. Despite the significant fraction of proviral DNA represented by replication-deficient sequences, the archived virus has an enormous potential for viral complementation and survival as a pool of viral quasispecies. It is likely that the amount of integrated provirus and extent of its diversity play important role in establishing and maintaining dual, triple and superinfections. Therefore, the contribution of accumulating provirus to the increase of viral diversity in the course of HIV-1 infection should not be underestimated.
A diverse distribution of HIV-1 subtypes within the HIV/AIDS epidemic has resulted in worldwide dominance by HIV-1 subtype C (Hemelaar et al., 2006; McCutchan, 2006; Osmanov et al., 2002) . It is believed that the highest incidence and prevalence of HIV-1 infection in the world is caused by subtype C in southern African countries. Significant progress has been made recently in studying HIV-1 subtype C (Bredell et al., 2007; Coetzer et al., 2007; Ndung'u, Renjifo, and Essex, 2001; Ndung'u et al., 2000 Ndung'u et al., , 2006 Novitsky et al., 2002a Novitsky et al., , 2001a Novitsky et al., , 2003 Novitsky et al., , 2001b Novitsky et al., , 2002b Novitsky et al., , 2007a Rademeyer et al., 2004; Rong et al., 2007a; van Harmelen et al., 1998 van Harmelen et al., , 2001 van Harmelen et al., , 1997 van Harmelen et al., , 1999 Williamson et al., 1995 Williamson et al., , 2003 Williamson, 2003; Zhang et al., 2005 Zhang et al., , 2006 , providing strong evidence for subtype-specific differences on genetic and functional levels (Gnanakaran et al., 2007; Li et al., 2006a; Rademeyer et al., 2007; Rong et al., 2007b) . However only few recent studies addressed viral quasispecies in HIV-1 subtype C infection (Rong et al., 2007a; Rousseau et al., 2008; Salazar-Gonzalez et al., 2008) . Lingering evolution of subtype C quasispecies is understudied, at least as compared with a series of comprehensive studies on evolution of subtype B viruses (Delwart et al., 2002; Freel et al., 2003; Frost et al., 2005; Gottlieb et al., 2008; Herbeck et al., 2006; Keele et al., 2008; Learn et al., 2002; Leitner, Kumar, and Albert, 1997; Ritola et al., 2004; Shankarappa et al., 1999) . A thorough analysis of the sequence of transmitted viruses and the structures of their envelopes may yield clues to help guide vaccine design (Johnston and Fauci, 2007) .
It is believed that the population of viral quasispecies in acute HIV-1 infection is relatively uniform; however both homogeneous and heterogeneous virus populations have been reported at or soon after virus transmission (Delwart et al., 1994; Gottlieb et al., 2007a Gottlieb et al., , 2008 Keele et al., 2008; Learn et al., 2002; Long et al., 2000; Markham et al., 1998; Poss et al., 1995; Salazar-Gonzalez et al., 2008; Shankarappa et al., 1999; Wolfs et al., 1992; Zhang et al., 1993; Zhu et al., 1993) . A linear increase of viral diversity was estimated at the level of about 1% per year in the C2-V5 region of HIV-1 subtype B env (Herbeck et al., 2006; Shankarappa et al., 1999) .
Selection pressure is distributed unevenly across HIV-1 Env (Choisy et al., 2004; Gaschen et al., 2002) with clear subtype-specific differences (Gnanakaran et al., 2007) . In HIV-1 subtype C, the C3 region of gp120 includes the highly variable α2-helix and, together with the V4 region, was shown to be the main target for early neutralizing antibodies (NeuAb) (Moore et al., 2008) . Shorter lengths of V1-V5 loops and fewer glycosylation sites, particularly in the V1-V2 region, were associated with development of early strain-specific NeuAb . The number of potential N-linked glycosylation sites (PNGS) and the sequence length of the C2-V5 region of Env were shown to be relatively stable in infants infected with HIV-1 subtype C (Zhang et al., 2005) .
The goals of this case series study were to characterize the evolution of gp120 in acute subtype C infection, to test whether viral diversity and diversification differ between viral RNA load phenotypes of slow and fast decline, and to evaluate changes in the length of variable loops and the number of PNGS in acute HIV-1 subtype C infection in adults.
Results
Two distinct viral RNA phenotypes were evident at the very early stage of HIV-1 subtype C infection (Fig. 1A , individual curves of viral RNA load, and 1B, early viral RNA set point). The line of evidence for viral RNA phenotypes included the following: 1) differences in decline of viral RNA from peak between groups was confirmed by levels of viral RNA and slopes of viral RNA decline within first 2 months postseroconversion; 2) differences in the level of an early viral RNA set point from 50 to 200 days post-seroconversion; 3) differences in the levels of CD4+ T cell counts; and 4) difference in decline of CD4+ T cells below 200 within 1 year after seroconversion. The observed phenotypes of viral RNA, namely slow and fast decline of viral RNA, provided a rationale for looking for potential differences in early viral evolution among subjects experiencing either slow or fast decline of viral RNA at early stage of HIV-1 infection. We hypothesized that viral diversity and diversification are higher in subjects with slow decline of viral RNA and high early viral RNA set point. Conversely, subjects with fast decline of viral RNA and a low level of early viral RNA set point have lower viral diversity and diversification.
Phylogenetic relationships
All eight subjects in this study were infected by HIV-1 subtype C, which was evident by clustering with four HIV-1 subtype C references (Fig. 2) . Clustering with subtype C references was supported in the NJ analysis by bootstrap value of 100 (data not shown). The evolutionary history of proviral sequences was inferred by the maximum likelihood method. As expected, viral quasispecies belonging to different subjects formed distinct clusters (Fig. 2) . Subjects with slow decline of viral RNA and a high early viral RNA set point (shown in red) generally had longer and more diversified branches while subjects with fast decline and low early viral RNA set point (shown in green) demonstrated more compact branches in the phylogenetic tree. Two subjects from the group with slow decline of viral RNA, 1811 and 5018 demonstrated distinct intra-patient clusters of quasispecies suggesting a potential infection with more than a single viral variant. The topology of viral sequences along the branches connecting two intrapatient clusters suggested a potential recombination between viral quasispecies belonging to different clusters.
To test the possibility of dual infection, genetic pairwise distances between subjects' MRCA were compared with intra-patient distances including total and intra-cluster distances for cases 1811 and 5018 (Fig.  3) . Distances between subjects' MRCA had a mean of 25.2% ± 3.2% ranging from 18.3% to 30.5%. The total intra-patient distances in 1811 and 5018 were 3.3% ± 2.3% and 1.7% ± 1.7%, respectively, while intracluster distances were 0.8% ± 0.5% and 0.7% ± 0.5% in subject 1811, and 0.4% ± 0.5% and 1.1% ± 0.3% in subject 5018. Not surprisingly, the pairwise intra-patient distances between clusters accounted for the upmost level of viral intra-patient diversity and were 5.9% ± 0.5% and 4.1% ± 0.4% in 1811 and 5018, respectively. All intra-patient distances in cases 1811 and 5018 were significantly lower than inter-patient distances (p b 0.001 for all comparisons). Therefore, the comparison of inter-and intra-patients distances, and the branch topology in the phylogenetic tree provided evidence that subjects 1811 and 5018 are unlikely to be dually infected with distinct unrelated viral isolates. In contrast, both cases 1811 and 5018 are more likely to represent HIV-1 infection with more than a single viral variant that apparently originated from the pool of diversified viruses at the time of transmission or multiple transmission events from the same (per subject) donor.
We tested 1811 or 5018 sequences for potential recombinants. The presence of breakpoint in bootstrap sliding window analysis was used as criteria for recombination. The branch topology allowed us to identify potential candidates located in-between clusters that are likely to represent recombinants between clusters. In case 1811, ten sequences originating from 91 to 350 days after seroconversion were identified as potential recombinants (Fig. 4A) . In nine cases breakpoints were identified and these sequences were classified as recombinants. No evidence for recombination was found in a single sequence 350.08. The location of breakpoints was not uniform suggesting a number of independent recombination events. The breakpoints at the end of V3 loop and on the edge of C3 region and V4 loop were observed in multiple viral variants. A total of eight sequences were tested for potential recombination in subject 5018 (Fig. 4B ). Only two sequences sampled at day 97 after seroconversion demonstrated breakpoints. None of the remaining sequences tested provided evidence for recombination.
The overall topology of gp120 sequences in subject 1811 suggested a congruent evolution of viral quasispecies within two clusters accompanied by recombination of viral variants between clusters. Interestingly, the cluster 2 was represented by a minor viral variant at 16 days but by a major variant at 97 days, implying a dynamic interplay between apparent immune pressure and virus over the first 3 months after seroconversion. In subject 5018, viral variants representing the seroconversion sequences (shown by a diamond) were evident in cluster 1, but were not seen in cluster 2. It is possible that viral variants representing cluster 2 did exist at the time of seroconversion but were not amplified apparently due to a low copy number.
Diversity and diversification
Viral population heterogeneity of the proviral gp120 was studied prospectively over the first year after seroconversion (Fig. 5A ). The population of proviral quasispecies was relatively homogeneous at seroconversion evident from a mean value of 0.21% ± 0.15% and a tight range from 0.015 to 0.36% in most subjects except the case 1811 infected with more than a single viral variant. At day 16, the overall diversity in subject 1811 was 1.45% ± 2.24% but only 0.35% ± 0.23% within cluster 1 (no data for cluster 2 because a single sequence available at day 16). At seroconversion, the extent of proviral diversity did not differ between subjects with slow and fast decline of viral RNA (p = 0.18 and p = 0.09 for uncorrected and cluster-corrected comparisons). However after seroconversion, proviral diversity in gp120 varied between subjects and the difference reached statistical significance between groups with different viral RNA phenotype. Fig. 5B demonstrates that proviral diversity in subjects with slow decline of viral RNA is higher than in subjects with fast decline of viral RNA load. During the first 200 days after seroconversion, the mean diversity was 0.24% ± 0.18% in the group with fast decline of viral RNA, while it was 1.40% ± 0.65% and 0.73% ± 0.22% for uncorrected and cluster-corrected distances in the group with slow decline of viral RNA ( Fig. 5C ; p = 0.029 and p = 0.006 for uncorrected and cluster-corrected comparison, respectively). However, the significance between groups was lost at later time points, in part, probably due to increased fluctuations apparent from high standard deviations in groups (Fig. 5C; 201+ days comparisons) . A gradual increase of proviral diversity was evident by positive slopes in all subjects by 200 days after seroconversion, ranging from 7.6E-06 in subject 3603 to 2.0E-04 in subject 1811. Slopes of proviral diversity differed between groups of viral RNA phenotypes and were higher in subjects with slow decline of viral RNA for the period 0 to 200 days after seroconversion (p = 0.031). By the end of the first year of infection the mean diversity of proviral The level of viral RNA at early set point was defined as a mean ± standard deviation of measurements from 50 to 200 days from detected seroconversion (after assuming reduction of viral RNA peak). N shows the number of viral RNA measurements for the period from 50 to 200 days per subject. Dashed line shows a median of early viral RNA set point computed for all eight subjects at 4.53 log 10 copies/ml. The first four subjects 1811, 2865, 3312, and 5018 correspond to the group of slow decline of viral RNA and high early viral RNA set point. Subjects 3430, 3505, 3603, and 5582 correspond to the group of fast decline of viral RNA and low early viral RNA set point. Fig. 2 . Phylogenetic relationships of gp120 sequences in acute HIV-1 subtype C infection. A phylogenetic tree was generated by PhyML (Guindon and Gascuel, 2003 ) using the HKY model for nucleotide substitution, and visualized in FigTree v.1.1.2 (Rambaut, 2008) . Main branches are labeled with subjects' numbers. Coloring corresponds to the viral RNA phenotypes: subjects with slow decline of viral RNA and a high early viral RNA set point are shown in red, and subjects with fast decline of viral RNA and a low early viral RNA set point are shown in green. Clusters are highlighted for subjects 1811 and 5018. HIV-1 subtype reference sequences are shown in blue. The cluster of all HIV-1 M group non-subtype C references is shown at the bottom. quasispecies in gp120 increased to 1.72% ± 1.04% for uncorrected and 1.32% ± 0.76% for the cluster-corrected distances. The diversity was higher in the group with slow decline of viral RNA at the time period 301+ days in the uncorrected analysis (p = 0.015; 95% CI for difference of means 0.54 to 2.87) but was not seen in the cluster-corrected analysis (p N 0.05).
The shape of viral diversification resembled graphs of viral diversity (Fig. 6A) . The mean diversification of viral quasispecies from MRCA for the period from 0 to 200 days after seroconversion was 1.02% ± 1.04% and 0.89% ± 0.86% for uncorrected and clustercorrected distances, respectively. For the later time points, the mean diversity from MRCA increased to 1.25% ± 0.79% and 1.57% ± 1.17% for uncorrected and cluster-corrected distances, respectively. This was close but a little higher than the previously reported 1%-per-year increase of env C2V5 diversity in HIV-1 subtype B infection (Herbeck et al., 2006; Shankarappa et al., 1999) . Similarly to proviral diversity, viral diversification from MRCA differed between the viral RNA phenotypes. During 0 to 200 days after seroconversion diversity from MRCA reached 1.74% ± 1.04% and 2.01% ± 1.40% for uncorrected and corrected distances in the group with slow decline of viremia, while remaining at mean of 0.30% ± 0.22% in subjects with fast decline of viral RNA load ( Fig. 6B ; p = 0.029 and p = 0.044 for uncorrected and cluster-corrected comparisons). At later time points, only a trend to a higher viral diversification from MRCA was observed in the group with slow decline of viral load (p = 0.095 and p = 0.079 for uncorrected and cluster-corrected comparisons), which can be attributable to higher inter-patient variation and relatively small sample size.
Length of variable loops and number of PNGS
To address changes in length of variable loops in proviral gp120, we quantified the amino acid length of five variable loops and C3 region over the first year of infection and computed the difference in amino acid length from the time of seroconversion (Fig. 7A) . We found no or minimal change in the length of variable loops in HIV-1 subtype C infection over the first year after seroconversion. The V1 loop was predominantly reduced, which was evident by negative slopes in five out of eight subjects. In the V2 loop, three cases had a slight increase, while three subjects had no length change and two had decreases in length. The length of the V3 loop and the C3 region virtually did not change over the first year of infection. The V4 loop was reduced in two cases of infection with multiple viral variants (subjects 1811 and 5018), and was almost unchanged in the other six subjects. The V5 loop length was unchanged in three, decreased in four, and increased in one subject. Interestingly, while there were minimal or no change in length of variable loops within clusters (cases 1811 and 5018), the length of variable loops differed between clusters. For example, clusters in subject 1811 showed lengths of 26 and 22 aa in V1, 48 and 43 aa in V2, 52 and 51 aa in C3 region, and 30-31 and 26 aa in V4. Clusters in subject 5018 were different only in V4 loop, demonstrating lengths of 29 and 26 aa. No difference in the V-loop length was found between groups with slow and fast decline of viral load (data not shown).
The number of PNGS was relatively stable and the mean values fluctuated within ±one amino acid within the first year of HIV-1 subtype C infection (Fig. 7B) . The overall pattern of changes in the number of PNGS was similar to the amino acid length changes over time. The number of PNGS in the V1 loop showed negative slopes in five out of eight cases. Changes in the V2 and V3 loops were minimal. In the C3 region, an increase of the number of PNGS was seen in four out of eight subjects including subject 3505 who increased the number of PNGS gradually from 2 to 3 over the first year of infection. In the V4 loop, the number of PNGS increased in 3 subjects, stayed unchanged in one subject, and decreased in 4 cases. The number of PNGS in the V5 loop showed an increase in 3 cases, stayed unchanged in 2 cases, and decreased in 3 cases. Some differences between the number of PNGS were observed between clusters in subjects 1811 but not in subject 5018. Thus, clusters in subject 1811 had 3 and 2 PNGS in V2, 2 and 3 PNGS in C3 region, 4 and 3 PNGS in V4, and did not differ in V1, V3, and V5 loops. No significant differences in the number of PNGS between groups with slow and fast decrease of viral load were found (data not shown).
Discussion
A better understanding of early events in HIV-1 subtype C infection may facilitate proper intervention strategies and better vaccine design. We analyzed the evolution of proviral quasispecies in the V1C5 region of gp120 during the first post-seroconversion year in eight acute cases of HIV-1 subtype C infection from Botswana. Despite the inherent limitations of a small sample set, the results of this study provide evidence that viral evolution in subtype C infection might have some specific characteristics. First, infection with more than a single viral variant is not rare in HIV-1 subtype C infection. Second, early viral RNA set point from 50 to 200 days post-seroconversion seems to be associated, at least temporarily, with proviral diversity and diversification in subtype C gp120. Third, no pattern of increase in the length of variable loops was observed. Fourth, the increase in the number of PNGS in proviral gp120 was clearly not a dominant pattern of viral evolution over the first post-seroconversion year.
Two out of eight subjects in this study were infected with more than a single variant of subtype C viruses. Dual infections originating from multiple transmissions of non-related viruses from multiple donors ("multiple donors to a single recipient transmission") were ruled out based on phylogenetic analysis and comparison of inter-and intra-patient pairwise distances. The most plausible explanation of cases 1811 and 5018 is a transmission of diversified viral variants from a single (per subject) donor. Multiple transmissions from the same Fig. 3 . A comparison of inter-patient viral diversity in 8 subjects and intra-patient diversity in subjects 1811 and 5018. Pairwise maximum likelihood distances are shown. The inter-patient viral diversity was quantified as pairwise distances between MRCA of 8 subjects. The intra-patient diversity was measured as pairwise distances between viral quasispecies within each subject or each cluster. Distance between clusters were compared by quantifying pairwise distances between sequences belonging to each cluster. In the box plots: the boundary of the box closest to zero indicates the 25th percentile, a solid line within the box marks the median value, a dashed line within the box shows the mean, and the boundary of the box farthest from zero indicates the 75th percentile. Whiskers above and below the box indicate the 10th and 90th percentiles. Points above and below the whiskers indicate outliers outside the 10th and 90th percentiles. Fig. 4 . Analysis for potential recombination in subjects 1811 and 5018. Distinct clusters and potential recombinants are defined. Each sequence is shown by a symbol corresponding to time points of sampling followed by number of days from detected seroconversion and ID of viral quasispecies. The recombinant search was performed by bootstrap analysis in the SimPlot program (Lole et al., 1999) . The HIV-1 group M ancestor sequence was used as outlier (blue line). Arrows on the top of bootstrap graphs designate potential breakpoints of recombination between viral variants. The location of variable loops in gp120 is shaded. (A) Subject 1811. Time points of sampling are shown by a diamond at 16 days, a triangle to the bottom at 91 days, a circle at 260 days, and a square at 350 days. The 16 day sequences in cluster 1 and sequence 016.01 were used as references for the first (red) and second (green) clusters. The red and green lines correspond to bootstrap values per sliding window. (B) Subject 5018. Time points of sampling are designated by a diamond at day 0, a triangle to the bottom at 97 days, a circle at 171 days, a triangle to the top at 203 days, a cross at 295 days, and a square at 387 days. The 0 time point sequences in cluster 1 and majority consensus sequence for the entire cluster 2 were used as references for the first and second cluster (red and green lines correspond to bootstrap values, respectively).
donor occurring over time cannot be ruled out, and apparently are likely to happen. Both cases of infection with more than a single viral variant in this study had a high viral load accompanied by fast decline of CD4+ T cells, which was consistent with described previously rapid disease progression of HIV-1 superinfection (Gottlieb et al., 2004 (Gottlieb et al., , 2007b Grobler et al., 2004; Jost et al., 2002; Liu et al., 1997; Sagar et al., 2003) . Infection with multiple viral variants dramatically increases the overall viral diversity and may lead to recombinant viral variants within a short period of time. It is likely that multiple viral variants might contribute to fast exhaustion of immune response and a reduced capacity of the immune system to contain viral replication. While elevated levels of proviral diversity and diversification in cases with multiple viral variants are readily predicted, no difference in the length of variable loops or number of PNGS was found between HIV-1 subtype C infections with single or multiple viral variants except V4 reduction in both 1811 and 5018 cases. Overall, these findings are consistent with previous reports on infections with multiple viral variants in HIV-1 subtype C (Coetzer et al., 2007; Grobler et al., 2004; Williamson et al., 2008) , although most previous studies did not separate infections originating from multiple donors and infections with diversified viruses from a single donor. In Tanzania, the frequency of HIV-1 infections with multiple viral variants ranged from 9% to 19% depending on the risk (Herbinger et al., 2006) , and was up to 25% in a high-risk cohort (McCutchan et al., 2004) . Whether frequency of multiple infections differs between HIV-1 subtypes is still unknown, as well as the mechanistic reason for HIV-1 infections with multiple viral variants. What is important is that HIV-1 infections with multiple viral variants present an additional challenge for vaccine development.
Results of this study suggest the existence of differential pathways of viral evolution during the early phase of HIV-1 subtype C infection. Our data support the idea that viral population is relatively homogeneous at the time of seroconversion (Gottlieb et al., 2007a; Shankarappa et al., 1999; Zhu et al., 1993) , unless subjects are infected with more than a single viral variant, in which case virus population is predictably heterogeneous. We report different patterns of viral evolution dependent on the decline of viral RNA and the early viral RNA set point, which is consistent with Fig. 5 . Intra-patient viral diversity in gp120. Mean values ± standard deviation of pairwise maximum likelihood nucleotide distances are shown. The timeline shows days from detected seroconversion. (A) Individual trajectories of viral diversity in gp120. Numbers within boxes correspond to subject cases. The extent of total viral diversity per time point per subject is shown by crosses. The intra-cluster diversity in subjects 1811 and 5018 is designated by triangles (recombinant sequences are removed). Dotted lines with arrows indicate initiation of ART. (B) Levels of proviral diversity in gp120 between subjects with slow (filled circles) and fast (open circles) decline of viral RNA. (C) Viral diversity within groups defined on viral RNA decline, fast and slow decline of viral RNA. The slow decline group is presented by uncorrected distances (defined as total intra-patient pairwise distances) and cluster-corrected distances (sequences within clusters used separately, no recombinants included). Analysis was performed for two time intervals: 0 to 200 days and 201+ days after seroconversion. Comparison between groups is performed by t-test or Mann-Whitney Rank Sum Test (shown with ⁎).
the assumption that higher levels of viral replication cause higher levels of viral diversity and diversification over time. In subjects with suboptimal suppression of viral replication after seroconversion we observed higher viral diversification. In contrast, in subjects with efficient suppression of viral replication, at least by 200 days after seroconversion, the diversification of virus was lower. Three out of four subjects with more diversified proviral gp120 dropped CD4+ T cell count below 200 within the first year after seroconversion and initiated ARV treatment, while none of four subjects with lower proviral diversity did. Whether ARV treatment alters proviral diversity in HIV-1 subtype C gp120 needs to be addressed in future studies.
We found no or minimal length variation in variable loops and the number of PNGS in gp120 during the first year after seroconversion, which is consistent with the recent report from South Africa (Coetzer et al., 2007) . In contrast, studies from Zambia suggested preferential transmission of HIV-1 subtype C with compact variable loops and a reduced number of PNGS (Derdeyn et al., 2004; Li et al., 2006a) . Transmission of viruses with shorter and less glycosylated Env implies a gradual increase in variable loop Fig. 6 . Diversification of viral gp120 in acute HIV-1 subtype C infection. Mean values ± standard deviation are shown. Viral diversification at each time point was compared to the persubject MRCA sequence reconstructed from viral quasispecies at all time points (red triangle), and consensus sequence reconstructed from the earliest available quasispecies (green square). The timeline shows days from detected seroconversion. (A) Individual trajectories of viral diversification. Numbers within boxes correspond to subject cases. Dotted lines with arrows indicate initiation of ART. (B) Viral diversification from MRCA that was reconstructed from viral quasispecies is compared between groups defined on viral RNA phenotype, fast and slow decline of viral RNA. The slow decline group is presented in two ways: by uncorrected distances (defined as total intra-patient pairwise distances to MRCA) and cluster-corrected distances (defined as intra-cluster pairwise distances to MRCA, no recombinants were included). Analysis was performed for two time intervals: 0 to 200 days and 201+ days after seroconversion. Comparison between groups is performed by t-test or Mann-Whitney Rank Sum Test (shown with ⁎).
length and in the number of PNGS over the course of infection, which has not been confirmed experimentally. While shorter variable loops in natural subtype C infections are more likely to induce broad NeuAb, no association between the number of PNGS and induction of NeuAb was reported (Rademeyer et al., 2007) . The loop length and the number of PNGS differ between HIV-1 subtypes. For example, newly transmitted subtype B viruses have longer and more glycosylated gp120 than newly transmitted subtype C viruses (Li et al., 2006b) , and V1V2 loops are shorter in subtype A infections (Chohan et al., 2005) . However within HIV-1 subtype C no difference in the length of variable loops between newly transmitted and chronic viruses has been reported (Li et al., 2006b) , which is consistent with our findings. The number of PNGS in variable loops of Env showed minimal fluctuations and no clear patterns of intra-and inter-subject variation of PNGS were observed over the first year of HIV-1 subtype C infection.
In summary, the results of the study suggest that the frequency of HIV-1 subtype C infections with more than a single viral variant is not rare and provide a characterization of the proviral evolution of gp120 in an early phase of HIV-1 subtype C infection. We found differential pathways of viral evolution dependent on viral replication during the first 200 days after. There was minimal evolution of the variable loop length and the number of PNGS over the first year of HIV-1 subtype C infection.
Methods

Study subjects
Eight cases of acute HIV-1 subtype C infections were identified as part of a primary HIV-1 infection study in Botswana (Novitsky et al., 2007b) , approved by the Institutional Review Boards in Botswana and the US. A positive HIV-1 RT-PCR accompanied by a negative HIV-1 serology, the RNA + Ab − status was used as inclusion criteria for enrollment. Following identification as being acutely infected with HIV, participants had weekly and bi-weekly visits for the first 4 months, and monthly visits for the following 8 months. The analyzed subjects included 2 males and 6 females whose age ranged from 20 to 53 years old. The mean value of viral RNA peak was 6.25 ± 0.92 log 10 copies/ml. Two patterns in evolution of viral RNA and CD4+ T cells were evident suggesting slow or fast decline of viral RNA during the first two post-seroconversion months (5.47 ± 0.46 vs. 3.72 ± 0.65 log 10 ; p = 0.005). While the viral RNA peaks did not differ between subjects with slow or fast decline of viral RNA (6.79 ± 0.97 log 10 vs. 5.72 ± 0.53 log 10 for slow and fast decline, respectively; 95% CI for difference of means: −0.28 to 2.41; p = 0.10), the rates of viral RNA decline measured by slopes were different between groups (−0.0128 ± 0.0058 log 10 per day vs −0.0275 ± 0.0082 log 10 per day for groups with slow and fast RNA decline, respectively; p = 0.03). The assumption was made that the peak of viral RNA should decline by day 50 after seroconversion. The early viral RNA set point defined as mean ± standard deviation of plasma RNA measurements from 50 to 200 days differed between subjects with slow and fast decline of viral RNA ( 
Single genome amplification and sequencing
The proviral DNA was amplified from PBMC isolated at multiple visits from seroconversion up to 440 days thereafter. In this study, time 0 corresponded to the time of seroconversion. A strategy of single-genome amplification by limiting dilutions and sequencing close to the recently published method with some modifications was employed. The targeted region of proviral gp120 spanned the V1 loop to the C terminus end of gp120, V1C5, and corresponded to nucleotide positions 6615 to 7757 of HXB2 (amino acids 131 to 511 in relation to the gp120 CDS in HXB2). Amplicons were purified by Exo-SAP (Dugan et al., 2002) , and sequenced directly on the ABI 3730 DNA Analyzer using the BigDye technology. About 10 viral sequences per subject per time point were analyzed. The obtained sequences were tested by HYPERMUT v.2.0 (Rose and Korber, 2000) and hypermutated sequences were excluded. Diversity of quasispecies, divergence from the most recent common ancestor (MRCA) and earliest viral quasispecies over time, length of variable loops, and number of PNGS were longitudinally characterized. Sequences from ARV-treated subjects 1811, 2865, and 3312 were included in the analysis. Time of ART initiation is indicated by arrows in Figs. 5 and 6.
Diversity and divergence
Alignment of nucleotide sequences was performed and refined by Muscle (Edgar, 2004) followed by a manual adjustment in BioEdit (Hall, 1999) . The maximum-likelihood (ML) method was used to estimate pairwise nucleotide distances. PAUP⁎ version 4.0 (Swofford, 2003) and Modeltest version 3.7 (Posada and Buckley, 2004; Posada and Crandall, 1998) with the Akaike information criterion were utilized to identify an appropriate substitution model. The identified substitution model was used in PAUP⁎ to estimate ML-corrected pairwise distances. The proviral diversity per subject per time point was computed as a mean value ± standard deviation of pairwise distances between proviral quasispecies at the given time point. The mean values and standard deviations are shown in figures as fractions of 1, and presented as percentages in the text for convenience. Quantification of viral diversification was performed by using a mean value ± standard deviation of pairwise distances between viral quasispecies at the given time point and a subject's MRCA or consensus sequence of the viral quasispecies from the earliest time point. The MRCA for each subject was reconstructed at the basal node of viral quasispecies collected at all time points using ML criteria in PAUP⁎. The alignment was gap-stripped, and single sequences from other seven subjects were used as outgroups, as described elsewhere (Learn et al., 2002) . The majority consensus sequence for the earliest quasispecies was built in BioEdit.
Phylogenetic analysis
The genealogy reconstruction of the proviral sequences was implemented in PhyML (Guindon and Gascuel, 2003 ) using the HKY model of nucleotide substitution. The branching topology of generated maximum-likelihood phylogenetic tree in PhyML was comparable with NJ trees generated by MEGA4. Only maximum likelihood trees visualized by FigTree v1.1.2 (Rambaut, 2008) are presented. For HIV-1 subtyping purpose, a total of 35 reference sequences representing HIV-1 M group subtypes from A to H from Los-Alamos HIV Sequence Database (http://www.hiv.lanl.gov/) were included in the analysis.
Statistical methods
Data are summarized with means ± standard deviations and correlations. Comparisons between groups, including grouping of subjects with slow and fast decline of viremia, were based on t-tests and Mann-Whitney Rank Sum tests for continuous and binary outcomes, respectively. All reported p-values are 2-sided. subtype C infection study in Botswana, the Tshedimoso study, was supported and funded by NIH grant R01 AI057027. This work was supported in part by the NIH grant D43 TW000004 (DN) and also through the AAMC FIC/Ellison Overseas Fellowships in Global Health and Clinical Research (LK and RR).
Nucleotide sequence accession numbers
The generated sequences were deposited in the GenBank except excluded hypermutated sequences. The accession numbers of the deposited 444 sequences are FJ378092 to FJ378535.
